➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
Dow
Moodys
McKesson

Last Updated: December 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Purdue Pharma L.P. v. Intellipharmaceutics International Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-05-31 123 Notice of Service . Wuts, Ph.D. on the Invalidity of U.S. Patents Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics… 7 April 2017 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
2018-06-11 126 Notice of Service , Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…Non-Infringement of the Asserted Claims of the '993 and '919 Patents and Supplemental Expert Report of Neil E. Spingarn…Invalidity of the Asserted Claims of the '993 and '919 Patents; and (4) Rebuttal Expert Report of Peter G.M. Wuts… 7 April 2017 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
0000-00-00 130 Opinion - Memorandum Opinion of multiple terms in U.S. Patent Nos. 9,060,976 ("the '976 patent"), 9,073 ,933 ("…construction for multiple terms in U.S. Patent Nos. 9,060,976, 9,073,933, 9,522,919, 9,492,389, and 9,…quot;the ' 933 patent"), 9,522,919 ("the ' 919 patent"), 9,492,389 ("the '…#39; 389 patent"), and 9,492,391 ("the '391 patent"). The Court has considered the…would infringe six of Plaintiffs' patents. (D.I. 1). The patents-in-suit relate to OxyContin®, an extended-release External link to document
0000-00-00 144 Notice of Service , Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,060,976; 9,492,389; 9,492,391 filed by Intellipharmaceutics… 7 April 2017 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
0000-00-00 204 Notice of Service Ph.D., on the Non-Infringement of U.S. Pat. Nos. 9,060,976; 9,492,389 filed by Intellipharmaceutics Corporation… 7 April 2017 1:17-cv-00392 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Express Scripts
Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.